Clinical focus: Rheumatoid arthritis
Articles (Rheumatoid arthritis)
Features, causes and diagnosis
Social and financial independence can be lost when a person develops severe rheumatoid arthritis. Prompt diagnosis and treatment can improve outcomes for patients and reduce costs to society
Evidence in support of early and aggressive pharmacological intervention in rheumatoid arthritis continues to be gathered. DMARDs, corticosteroids and biologics are the main drugs in the armoury
May 2010’s Lifelong Learning questions are based on the CLINICAL FOCUS articles on Rheumatoid arthritis, which were commissioned from independent authors.
The information below helps you to identify knowledge gaps and undertake continuing professional development.
The questions can be viewed/printed as a PDF (40K)
This online module is closed; the answers are here
How to undertake continuing professional development
Reflect on your gaps in knowledge
- How does rheumatoid arthritis (RA) affect the joints and what are some of the suggested causes?
- What are the main treatments for RA and what are their most common side effects?
- How can pharmacists help RA patients manage their medicines and health?
- Read the CLINICAL FOCUS articles in this issue (pp154-167)
- What have you learnt?
- How has it added to the value of your practice?
- What will you do now and how will this be achieved?
The Lifelong Learning questions on Rheumatoid arthritis have been approved by the Royal Pharmaceutical Society using an independent reviewer as a resource to support your professioal development.
Consider making this activity one of your nine CPD entries this year.
Citation: Clinical Pharmacist URI: 11010240
Recommended from Pharmaceutical Press